Differential expression of novel tyrosine kinase substrates during breast cancer development

Molecular and Cellular Proteomics

Volumn 6, Issue 12, 2007, Pages 2072-2087

  Chen, Yunhao ^a   Choong, Lee Yee ^a   Lin, Qingsong ^b   Philp, Robin ^c   Wong, Chee Hong ^d   Ang, Boon Keong ^d   Tan, Yee Ling ^a   Loh, Marie Chiew Shia ^d   Hew, Choy Leong ^b   Shah, Nilesh ^a   Druker, Brian J ^e   Chong, Poh Kuan ^a   Lim, Yoon Pin ^a,b,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c AGENCY FOR SCIENCE   (Singapore)

^d BIOINFORMATICS INSTITUTE   (Singapore)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; EPIDERMAL GROWTH FACTOR; GEFITINIB; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; TOLL INTERACTING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; DISEASE COURSE; DOWN REGULATION; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; HUMANS; IMMUNOHISTOCHEMISTRY; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTRATE SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 38349062653     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M700395-MCP200     Document Type: Article

References (48)

1. Clark, E. A., Golub, T. R., Lander, E. S., and Hynes, R. O. (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532-535
2. Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordon-Cardo, C., Guise, T. A., and Massague, J. (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537-549
3. Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., and Weinberg, R. A. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939
4. Dawson, P. J., Wolman, S. R., Tait, L., Heppner, G. H., and Miller, F. R. (1996) MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am. J. Pathol. 148, 313-319
5. Miller, F. R. (2000) Xenograft models of premalignant breast disease. J. Mammary Gland Biol. Neoplasia 5, 379-391
6. Chong, B. E., Hamler, R. L., Lubman, D. M., Ethier, S. P., Rosenspire, A. J., and Miller, F. R. (2001) Differential screening and mass mapping of proteins from premalignant and cancer cell lines using nonporous reversed-phase HPLC coupled with mass spectrometric analysis. Anal. Chem. 73, 1219-1227
7. Chong, B. E., Lubman, D. M., Miller, F. R., and Rosenspire, A. J. (1999) Rapid screening of protein profiles of human breast cancer cell lines using non-porous reversed-phase high performance liquid chromatography separation with matrix-assisted laser desorption/ionization time-of-flight mass spectral analysis. Rapid Commun. Mass Spectrom. 13, 1808-1812
8. Chong, B. E., Lubman, D. M., Rosenspire, A., and Miller, F. (1998) Protein profiles and identification of high performance liquid chromatography isolated proteins of cancer cell lines using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 12, 1986-1993
9. Starcevic, S. L., Diotte, N. M., Zukowski, K. L., Cameron, M. J., and Novak, R. F. (2003) Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD). Toxicol. Sci. 75, 74-81
10. Starcevic, S. L., Elferink, C., and Novak, R. F. (2001) Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease. J. Natl. Cancer Inst. 93, 776-782
11. Tang, B., Vu, M., Booker, T., Santner, S. J., Miller, F. R., Anver, M. R., and Wakefield, L. M. (2003) TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J. Clin. Investig. 112, 1116-1124
12. Worsham, M. J., Pals, G., Schouten, J. P., Miller, F., Tiwari, N., van Spaendonk, R., and Wolman, S. R. (2006) High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model. Breast Cancer Res. Treat. 96, 177-186
13. Chen, Y., Low, T. Y., Choong, L. Y., Ray, R. S., Tan, Y. L., Toy, W., Lin, Q., Ang, B. K., Wong, C. H., Lim, S., Li, B., Hew, C. L., Sze, N. S., Druker, B. J., and Lim, Y. P. (2007) Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells. Proteomics 7, 2384-2397
14. Lim, Y. P., Diong, L. S., Qi, R., Druker, B. J., and Epstein, R. J. (2003) Phosphoproteomic fingerprinting of epidermal growth factor signaling and anticancer drug action in human tumor cells. Mol. Cancer Ther. 2, 1369-1377
15. Lim, Y. P., Wong, C. Y., Ooi, L. L., Druker, B. J., and Epstein, R. J. (2004) Selective tyrosine hyperphosphorylation of cytoskeletal and stress proteins in primary human breast cancers: implications for adjuvant use of kinase-inhibitory drugs. Clin. Cancer Res. 10, 3980-3987
16. Lim, Y. P., Low, B. C., Lim, J., Wong, E. S., and Guy, G. R. (1999) Association of atypical protein kinase C isotypes with the docker protein FRS2 in fibroblast growth factor signaling. J. Biol. Chem. 274, 19025-19034
17. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Day, S., Daniels, S., Purkayastha, S., Juhasz, P., Martin, S., Bartlet-Jones, M., He, F., Jacobson, A., and Pappin, D. J. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3, 1154-1169
18. Gan, C. S., Chong, P. K., Pham, T. K., and Wright, P. C. (2006) Technical, experimental and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ). J Proteome Res. 6, 821-827
19. Blagoev, B., Ong, S. E., Kratchmarova, I., and Mann, M. (2004) Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. Nat. Biotechnol. 22, 1139-1145
20. Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., and Mann, M. (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635-648
21. Thelemann, A., Petti, F., Griffin, G., Iwata, K., Hunt, T., Settinari, T., Fenyo, D., Gibson, N., and Haley, J. D. (2005) Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells. Mol. Cell. Proteomics 4, 356-376
22. Zhang, Y., Wolf-Yadlin, A., Ross, P. L, Pappin, D. J., Rush, J., Lauffenburger, D. A., and White, F. M. (2005) Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol. Cell. Proteomics 4, 1240-1250
23. Brill, L. M., Salomon, A. R., Ficarro, S. B., Mukherji, M., Stettler-Gill, M., and Peters, E. C. (2004) Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry. Anal. Chem. 76, 2763-2772
24. Rush, J., Moritz, A., Lee, K. A., Guo, A., Goss, V. L., Spek, E. J., Zhang, H., Zha, X. M., Polakiewicz, R. D., and Comb, M. J. (2005) Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23, 94-101
25. Tao, W. A., Wolischeid, B., O'Brien, R., Eng, J. K., Li, X. J., Bodenmiller, B., Watts, J. D., Hood, L., and Aebersold, R. (2005) Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry. Nat. Methods 2, 591-598
26. Wolf-Yadlin, A., Hautaniemi, S., Lauffenburger, D. A., and White, F. M. (2007) Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc. Natl. Acad. Sci. U. S. A. 104 55860-5865
27. Blume-Jensen, P., and Hunter, T. (2001) Oncogenic kinase signalling. Nature 411, 355-365
28. Cabodi, S., Tinnirello, A., Di Stefano, P., Bisaro, B., Ambrosino, E., Castellano, I., Sapino, A., Arisio, R., Cavallo, F., Forni, G., Glukhova, M., Silengo, L., Altruda, F., Turco, E., Tarone, G., and Defilippi, P. (2006) p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cancer Res. 66, 4672-4680
29. Willis, S., Hutchins, A. M., Hammet, F., Ciciulla, J., Soo, W. K., White, D., van der Spek, P., Henderson, M. A., Gish, K., Venter, D. J., and Armes, J. E. (2003) Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers. Genes Chromosomes Cancer 36, 382-392
30. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177-182
31. Femandopulle, S. M., Cher-Siangang, P., and Tan, P. H. (2006) Breast carcinoma in women 35 years and younger a pathological study. Pathology 38, 219-222
32. Kanehisa, M. (11997) A database for post-genome analysis. Trends Genet. 13, 375-376
33. Kanehisa, M., and Goto, S. (2000) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27-30
34. Kanehisa, M., Goto, S., Hattori, M., Aoki-Kinoshita, K. F., Itoh, M., Kawashima, S., Katayama, T., Araki, M., and Hirakawa, M. (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 34, D354-D357
35. Bader, G. D., Donaldson, I., Wolting, C., Ouellette, B. F., Pawson, T., and Hogue, C. W. (2001) BIND - The Biomolecular Interaction Network Database. Nucleic Acids Res. 29, 242-245
36. Santner, S. J., Dawson, P. J., Tait, L., Soule, H. D., Eliason, J., Mohamed, A. N., Wolman, S. R., Heppner, G. H., and Miller, F. R. (2001) Malignant MCF10CA1 cell lines derived from premalignant human breast epitheliall MCF10AT cells. Breast Cancer Res. Treat. 65, 101-110
37. Malaney, S., and Daly, R. J. (2001) The ras signaling pathway in mammary turnorigenesis and metastasis. J. Mammary Gland Biol. Neoplasia 6, 101-113
38. Didierlaurent, A., Brissoni, B., Velin, D., Aebi, N., Tardivel, A., Kaslin, E., Sirard, J. C., Angelov, G., Tschopp, J., and Burns, K. (2006) Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide. Mol, Cell. Biol. 26, 735-742
39. Burns, K., Clatworthy, J., Martin, L., Martinon, F., Plumpton, C., Maschera, B., Lewis, A., Ray, K., Tschopp, J., and Volpe, F. (2000) Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-11 receptor. Nat. Cell Biol. 2, 346-351
40. Brissoni, B., Agostini, L., Kropf, M., Martinon, F., Swoboda, V., Lippens, S., Everett, H., Aebi, N., Janssens, S., Meylan, E., Felberbaum-Corti, M., Hirling, H., Gruenberg, J., Tschopp, J., and Burns, K. (2006) Intracellular trafficking of interleukin-1 receptor I requires Tollip. Curr. Biol. 16, 2265-2270
41. Katoh, Y., Imakagura, H., Futatsumori, M., and Nakayama, K. (2006) Recruitment of clathrin onto endosomes by the Tom1-Tollip complex. Biochem. Biophys. Res. Commun. 341, 143-149
42. Chen, R., Alvero, A. B., Silasi, D. A., and Mor, G. (2007) Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway. Am. J. Reprod. Immunol. 57, 93-107
43. Stubbs, M., McSheehy, P. M., and Griffiths, J. R. (1999) Causes and consequences of acidic pH in tumors: a magnetic resonance study. Adv. Enzyme Regul. 39, 13-30
44. De Milito, A., and Fels, S. (2005) Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol. 1, 779-786
45. Leoutsakou, T., Talieri, M., and Scorilas, A. (2006) Expression analysis and prognostic significance of the SRA1 gene, in ovarian cancer. Biochem. Bidphys. Res. Commun. 344, 667-674
46. Garg, M., Chaurasiya, D., Rana, R., Jagadish, N., Kanojia, D., Dudha, N., Kamran, N., Salhan, S., Bhatnagar, A., Suri, S., Gupta, A., and Suri, A. (2007) Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epitheliall ovarian cancer. Clin. Cancer Res. 13, 1421-1428
47. Kowalczyk, P., Woszczynski, M., and Ostrowski, J. (2002) Increased expression of ribosomal protein S2 in liver tumors, posthepactomized livers, and proliferating hepatocytes in vitro. Acta Biochim. Pol. 49, 615-624
48. Choong, L Y., Lim, S., Loh, M. C. S., Man, X., Chen, Y., Toy, W., Tan, Y. L., Pang, M., Chen, C. S., Poonepalli, A., Hande, P. M., Tan, P. H., Salto-Tellez, M., Wong, C. Y., Shah, N., Druker, B. J., and Lim, Y. P. (2007) Progressive loss of EGFR in a sub-population of breast cancers - implications in target-directed therapeutics. Mol. Cancer Ther. 6, 1-15